Join the RareGuru Community
To connect, share, empower and heal today.
Don’t fight Familial Alzheimer disease alone.
Find your community on the free RareGuru App.Familial Alzheimer disease (familial AD) is a degenerative disease of the brain that causes gradual loss of memory, judgment, and the ability to function socially. About 25% of all Alzheimer disease is familial (more than 2 people in a family have AD). When Alzheimer disease begins before 60 or 65 years of age (early-onset AD) about 60% of the cases are familial (also known as Early-onset familial AD). These cases appear to be inherited in an autosomal dominant manner.
There are three subtypes of early-onset familial AD which are each associated
with changes (mutations) in unique genes:
(1) Alzheimer disease, type 1 is caused by mutations in the
APP gene
(2) Alzheimer disease, type 3 is caused by mutations in the
PSEN1 gene
(3) Alzheimer disease, type 4 is caused by mutations in the
PSEN2 gene.
The condition known as late-onset familial AD includes only the subtype Alzheimer disease, type 2 and is associated with the APOE*4 allele on chromosome 19. This condition results in an increased risk of having AD.
Source: GARD Last updated on 05-01-20
Alzheimer disease (AD) is a degenerative disease of the brain that causes gradual loss of memory, judgment, and the ability to function socially. Alzheimer disease currently affects about 5 million people. About 75 percent of Alzheimer disease cases are classified as sporadic, which means they occur in people with no history of the disorder in their family. Although the cause of these cases is unknown, genetic changes are likely to play a role. Virtually all sporadic cases of Alzheimer disease begin after age 65, and the risk of developing this condition increases as a person gets older.
AD can be subdivided into two groups based on the age of onset:
(1) Early-onset (1%-6% of the cases) which start in people younger than 60- 65
years of age
(2) Late-onset, which starts in people older than 65 years old.
In about 25% of cases, AD is familial (2 or more people in a family have AD). For more information, please visit GARD's familial Alzheimer disease Web page.
Last updated on 05-01-20
About 75 percent of Alzheimer disease (AD) cases are classified as sporadic, which means that no other blood relatives are affected. The cause of these cases is not known at this time, but genetics may play a part. The risk of developing the condition increases as a person gets older.
The remaining 25 percent of Alzheimer disease cases are hereditary, which means they are caused by changes (mutated) genes and tend to cluster in families. These cases can be divided into early-onset familial disease (diagnosed before age 65) and late-onset familial disease.
Early-onset familial AD (AD subtypes 1, 3 and 4 caused by mutations in the APP gene, PSEN1 gene, and PSEN2 gene respectively) is inherited in an autosomal dominant manner and accounts for about 5% of the total cases of familial AD. The late-onset familial AD (AD subtype 4) is related to mutations in the _APOE _gene (e4 allele) and results in an increased susceptibility of having the disease.
Last updated on 05-01-20
No, only your personal health care provider can address your and your family's specific risks. However we have provided general information about the inheritance of Alzheimer disease in the questions and answers below. To learn about the risks specific to you and your family, we recommend that you speak with a genetics professional. A genetics professional can carefully review your family history to answer your specific questions. More information on how to find a genetics professional is available from the Genetics Home Reference at http://ghr.nlm.nih.gov/handbook/consult.
Last updated on 05-01-20
The Dominantly Inherited Alzheimer Network (DIAN) is an international partnership of leading scientists determined to understand dominantly inherited Alzheimer disease (DIAD). The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), the clinical research arm of DIAN, is dedicated to designing and managing interventional therapeutic trials for individuals with, and at risk of, DIAD. Click on the link to learn about their research efforts and see enrollment information for individuals and families who are impacted by DIAD or who are at risk for developing the disease.
Last updated on 04-27-20
Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!
To connect, share, empower and heal today.